.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
QuintilesIMS
Johnson and Johnson
Citi
Julphar
Fish and Richardson
Moodys
Cerilliant
US Department of Justice

Generated: December 17, 2017

DrugPatentWatch Database Preview

AFEDITAB CR Drug Profile

« Back to Dashboard

Which patents cover Afeditab Cr, and what generic alternatives are available?

Afeditab Cr is a drug marketed by Watson Labs and Watson Labs Teva and is included in two NDAs.

The generic ingredient in AFEDITAB CR is nifedipine. There are thirty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the nifedipine profile page.
Drug patent expirations by year for AFEDITAB CR

Pharmacology for AFEDITAB CR

Medical Subject Heading (MeSH) Categories for AFEDITAB CR

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson LabsAFEDITAB CRnifedipineTABLET, EXTENDED RELEASE;ORAL075659-001Oct 26, 2001AB1RXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs TevaAFEDITAB CRnifedipineTABLET, EXTENDED RELEASE;ORAL075128-001Mar 10, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Merck
Teva
Daiichi Sankyo
Argus Health
US Army
Fuji
Cantor Fitzgerald
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot